ArticleJournal of atherosclerosis and thrombosis2024

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan.

Kazunori Toyoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.